Startseite » Spektrum » Studien

Laufende Studien - Kooperation LMU

NEUROMUSKULÄR UND IMMUN

Studientitel

Start

Ende

Phase

AMG

Registrierung

Wertigkeit einer Gruppe von Biomarkern in der Differentialdiagnose von Kindern mit einer ersten demyelinisierenden Erkrankung des ZNS. Multicenter
Multiple Sklerose

2012

Laufend

 

 

nein

Connect (109 MS306) Open-Label, Randomized, Multicenter, Multiple-Dose,Active-Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children
Multiple Sklerose

2016

Ongoing

Phase 3

Neu

NCT 2013-002318-11 EudraCT Number: 2013-002318-11

SNT-III-012 - A Phase III Double blind, Randomized, Placebo Controlled Study assessing the Efficacy, Safety and Tolerability of Idebenone in Patients with Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids 2016

Ongoing

Phase 3

Neu

DMD/EudraCT Nr.: 2016-000602-10

DSC/14/2357/48 - Givinostat Randomised, double blind, placebo controlled, multicentre study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy

2018

Ongoing

Phase 3

Neu

DMD/EudraCT Nr.: 2016-000401-36

ATX-MTM-009 INCEPTUS - A Prospective, Non-Interventional Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects Aged 3 Years and Younger

2016 Ongoing

Natural history

Neu

MTM/EudraCT Nr.: 2015-003769-27

ATX-MTM-002 ASPIRO A Phase 1/2, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT132, an AAV8-Delivered Gene

2018

Ongoing

Phase 1-3
Neu

MTM/EudraCT Nr.: 2017-000876-27

HINE (ISIS 396443-CS11) An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443

2018

Ongoing

OLE

Neu

SMA/EudraCT Nr.: 2015-001870-16

CAT-1004-304:
POLARIS DMD single global Phase 3 trial called POLARIS DMD in Duchenne to evaluate the efficacy and safety of edasalonexent

2018

Ongoing

Phase 3

Neu

NCT 03703882

EPILEPSIE

A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety
and Tolerability of Topiramate as Monotherapy Compared With Levetiracetam as
Monotherapy in Pediatric Subjects With New or Recent-Onset Epilepsy

2018

 

Phase 3

Neu

KOPFSCHMERZ / MIGRÄNE

moma – modules on migraine activity
Strukturierte multimodale Frühintervention für Kinder mit Migräne im Alter von 6-11 Jahren

2018

2021

Nicht zutreffend

Neu

FASD / TESS

Deutsches FASD KOMPETENZZENTRUM Bayern

2018

2021

 

Ethikvotum